Calorie restriction and resveratrol in cardiovascular health and disease.

[1]  J. Vanamala,et al.  Resveratrol. , 2020, The Medical letter on drugs and therapeutics.

[2]  G. Maulucci,et al.  Sirt1 , 2012, Cell Cycle.

[3]  N. Sundaresan,et al.  Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy. , 2011, Journal of molecular and cellular cardiology.

[4]  B. Sümegi,et al.  Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. , 2011, The British journal of nutrition.

[5]  Wendy Keung,et al.  Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. , 2011, Biochimica et biophysica acta.

[6]  M. Sajan,et al.  Mechanisms for increased insulin-stimulated Akt phosphorylation and glucose uptake in fast- and slow-twitch skeletal muscles of calorie-restricted rats. , 2011, American journal of physiology. Endocrinology and metabolism.

[7]  S. Helfand,et al.  Comparative transcriptional pathway bioinformatic analysis of dietary restriction, Sir2, p53 and resveratrol life span extension inDrosophila , 2011, Cell cycle.

[8]  J. Dyck,et al.  Improved cardiac metabolism and activation of the RISK pathway contributes to improved post-ischemic recovery in calorie restricted mice , 2011, Journal of Molecular Medicine.

[9]  A. Fenning,et al.  Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. , 2011, Current pharmaceutical biotechnology.

[10]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[11]  A. Easton,et al.  Anti-angiogenic effects of resveratrol on cerebral angiogenesis. , 2011, Current neurovascular research.

[12]  S. Kume,et al.  Resveratrol Improves Oxidative Stress and Protects Against Diabetic Nephropathy Through Normalization of Mn-SOD Dysfunction in AMPK/SIRT1-Independent Pathway , 2011, Diabetes.

[13]  S. Shankar,et al.  Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor , 2010, PloS one.

[14]  S. Park,et al.  Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. , 2010, Molecular cell.

[15]  B. Yeğen,et al.  Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two‐kidney, one‐clip hypertensive rats , 2010, The Journal of pharmacy and pharmacology.

[16]  Hope D. Anderson,et al.  Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat. , 2010, American journal of hypertension.

[17]  Y. Day,et al.  Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. , 2010, Free radical biology & medicine.

[18]  N. Sundaresan,et al.  Abstract 19950: SIRT1-Mediated Deacetylation Promotes Akt Membrane Localization and Activation During Development of Cardiac Hypertrophy. , 2010 .

[19]  D. Seals,et al.  Life-long caloric restriction elicits pronounced protection of the aged myocardium: A role for AMPK , 2010, Mechanisms of Ageing and Development.

[20]  T. Slaga,et al.  Up-regulation of Adiponectin by Resveratrol , 2010, The Journal of Biological Chemistry.

[21]  Shih-Jen Chen,et al.  Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. , 2010, Journal of atherosclerosis and thrombosis.

[22]  C. Hermenegildo,et al.  Trans- but Not Cis-Resveratrol Impairs Angiotensin-II–Mediated Vascular Inflammation through Inhibition of NF-κB Activation and Peroxisome Proliferator-Activated Receptor-γ Upregulation , 2010, The Journal of Immunology.

[23]  F. Sellke,et al.  Resveratrol Improves Myocardial Perfusion in a Swine Model of Hypercholesterolemia and Chronic Myocardial Ischemia , 2010, Circulation.

[24]  V. Dolinsky,et al.  Calorie Restriction Prevents Hypertension and Cardiac Hypertrophy in the Spontaneously Hypertensive Rat , 2010, Hypertension.

[25]  W. Manning,et al.  Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. , 2010, Surgery.

[26]  R. de Cabo,et al.  Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2 , 2010, American journal of physiology. Heart and circulatory physiology.

[27]  D. Seals,et al.  Short‐term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress , 2010, Aging cell.

[28]  T. Netticadan,et al.  Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. , 2010, The Journal of nutrition.

[29]  Kuan‐Hsing Chen,et al.  Resveratrol ameliorates vasculopathy in STZ‐induced diabetic rats: role of AGE–RAGE signalling , 2010, Diabetes/metabolism research and reviews.

[30]  M. Molski,et al.  A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment. , 2010, European journal of medicinal chemistry.

[31]  M. Periasamy,et al.  Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. , 2010, American journal of physiology. Heart and circulatory physiology.

[32]  I. Rahman,et al.  SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol. , 2010, Biochemical and biophysical research communications.

[33]  Hope D. Anderson,et al.  Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. , 2010, American journal of hypertension.

[34]  K. Shimamoto,et al.  Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure* , 2010, The Journal of Biological Chemistry.

[35]  Venkataraman Thanabal,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[36]  H. Berrougui,et al.  A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. , 2009, Atherosclerosis.

[37]  N. Sundaresan,et al.  Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway* , 2009, The Journal of Biological Chemistry.

[38]  B. Viollet,et al.  AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol , 2009, Diabetes.

[39]  Z. Ungvari,et al.  Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells , 2009, American journal of physiology. Heart and circulatory physiology.

[40]  Liangyi Si,et al.  Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase. , 2009, Biochemical and biophysical research communications.

[41]  A. Sepici,et al.  Resveratrol Supplementation Gender Independently Improves Endothelial Reactivity and Suppresses Superoxide Production in Healthy Rats , 2009, Cardiovascular Drugs and Therapy.

[42]  H. Hayashi,et al.  Divergent regulation of adipose tissue metabolism by calorie restriction and inhibition of growth hormone signaling , 2009, Experimental Gerontology.

[43]  U. Förstermann,et al.  Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[44]  J. Auwerx,et al.  The Role of Sirtuins in the Control of Metabolic Homeostasis , 2009, Annals of the New York Academy of Sciences.

[45]  K. Pearson,et al.  Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1 , 2009, Mechanisms of Ageing and Development.

[46]  Sterling C. Johnson,et al.  Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.

[47]  Z. Ungvari,et al.  Resveratrol induces mitochondrial biogenesis in endothelial cells , 2009, American journal of physiology. Heart and circulatory physiology.

[48]  A. Bozzi,et al.  Resveratrol: a natural polyphenol with multiple chemopreventive properties. , 2009, Current drug metabolism.

[49]  J. Bennett,et al.  Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. , 2009, Free radical biology & medicine.

[50]  L. Rodríguez-Mañas,et al.  Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation , 2009, Aging cell.

[51]  K. Sunagawa,et al.  Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis , 2009, Hypertension Research.

[52]  Anita Y. M. Chan,et al.  Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1 , 2009, Circulation.

[53]  A. Zarzuelo,et al.  Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. , 2009, Biochemical pharmacology.

[54]  Corby K. Martin,et al.  Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. , 2009, Atherosclerosis.

[55]  R. Mueller,et al.  Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. , 2009, European journal of pharmacology.

[56]  S. Kihara,et al.  Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase* , 2009, Journal of Biological Chemistry.

[57]  D. Su,et al.  Sirt1 hyperexpression in SHR heart related to left ventricular hypertrophy. , 2009, Canadian journal of physiology and pharmacology.

[58]  B. Yeğen,et al.  Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage , 2009, Free radical research.

[59]  R. Bolli,et al.  Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. , 2008, American journal of physiology. Heart and circulatory physiology.

[60]  B. Viollet,et al.  AMPKalpha2 counteracts the development of cardiac hypertrophy induced by isoproterenol. , 2008, Biochemical and biophysical research communications.

[61]  B. Viollet,et al.  AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice , 2008, Hypertension.

[62]  Cheng-yao Wang,et al.  Resveratrol Attenuates Ventricular Arrhythmias and Improves the Long-Term Survival in Rats with Myocardial Infarction , 2008, Cardiovascular Drugs and Therapy.

[63]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[64]  W. Swindell.  Genes regulated by caloric restriction have unique roles within transcriptional networks , 2008, Mechanisms of Ageing and Development.

[65]  N. Maulik,et al.  Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. , 2008, Free radical biology & medicine.

[66]  R. Weindruch,et al.  Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart , 2008, Experimental Gerontology.

[67]  B. Viollet,et al.  Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt* , 2008, Journal of Biological Chemistry.

[68]  Leonid Peshkin,et al.  Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. , 2008, Cell metabolism.

[69]  F. Dominici,et al.  Insulin signaling cascade in the hearts of long-lived growth hormone receptor knockout mice: effects of calorie restriction. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[70]  Fan Lan,et al.  SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[71]  K. Sunagawa,et al.  SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[72]  F. Alt,et al.  Tissue-specific regulation of SIRT1 by calorie restriction. , 2008, Genes & development.

[73]  D. Allison,et al.  A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice , 2008, PloS one.

[74]  C. Silan,et al.  The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. , 2008, Biological & pharmaceutical bulletin.

[75]  Z. Ungvari,et al.  Resveratrol Prevents Monocrotaline‐induced Pulmonary Hypertension in Rats , 2008, Hypertension.

[76]  N. Maulik,et al.  Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium , 2008, Journal of cellular and molecular medicine.

[77]  Á. Tósaki,et al.  Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. , 2008, American journal of physiology. Heart and circulatory physiology.

[78]  E. Vahtola,et al.  Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat , 2008, Journal of hypertension.

[79]  Richard Weindruch,et al.  Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response , 2008, Aging cell.

[80]  L. Fontana.  Calorie restriction and cardiometabolic health , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[81]  Jin-Taek Hwang,et al.  Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells , 2008, Genes & Nutrition.

[82]  G. Tucker,et al.  Effects of dietary polyphenols on gene expression in human vascular endothelial cells , 2008, Proceedings of the Nutrition Society.

[83]  R. Bolli,et al.  Cardioprotective Effects of Short-Term Caloric Restriction Are Mediated by Adiponectin via Activation of AMP-Activated Protein Kinase , 2007, Circulation.

[84]  Andrew D. Steele,et al.  SIRT1 transgenic mice show phenotypes resembling calorie restriction , 2007, Aging cell.

[85]  Y. Higami,et al.  Down-regulation of AMP-activated protein kinase by calorie restriction in rat liver , 2007, Experimental Gerontology.

[86]  Q. Zhai,et al.  SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. , 2007, Cell metabolism.

[87]  Cuk-Seong Kim,et al.  SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.

[88]  J. Goodwin,et al.  Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  N. Maulik,et al.  Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. , 2007, Free radical biology & medicine.

[90]  Q. Tong,et al.  SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction , 2007, Aging cell.

[91]  S. Klein,et al.  Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial. , 2007, American journal of physiology. Endocrinology and metabolism.

[92]  J. W. Rush,et al.  Chronic Resveratrol Enhances Endothelium-Dependent Relaxation but Does Not Alter eNOS Levels in Aorta of Spontaneously Hypertensive Rats , 2007, Experimental biology and medicine.

[93]  P. Roca,et al.  Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage. , 2007, Cardiovascular research.

[94]  S. Vatner,et al.  Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart , 2007, Circulation research.

[95]  T. Netticadan,et al.  Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. , 2007, American journal of physiology. Heart and circulatory physiology.

[96]  Juei-Tang Cheng,et al.  Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. , 2007, Life sciences.

[97]  J. Crowell,et al.  Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[98]  Z. Ungvari,et al.  Resveratrol Increases Vascular Oxidative Stress Resistance , 2007, American journal of physiology. Heart and circulatory physiology.

[99]  J. Snipes,et al.  Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[100]  P. Puigserver,et al.  Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.

[101]  V. Dolinsky,et al.  Role of AMP-activated protein kinase in healthy and diseased hearts. , 2006, American journal of physiology. Heart and circulatory physiology.

[102]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[103]  S. Bolling,et al.  Moderate calorie restriction improves cardiac remodeling and diastolic dysfunction in the Dahl-SS rat. , 2006, Journal of molecular and cellular cardiology.

[104]  Y. Higami,et al.  Calorie restriction initiated at middle age improved glucose tolerance without affecting age-related impairments of insulin signaling in rat skeletal muscle , 2006, Experimental Gerontology.

[105]  Heng Ma,et al.  Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats. , 2006, Vascular pharmacology.

[106]  L. Hung,et al.  Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. , 2006, American journal of physiology. Endocrinology and metabolism.

[107]  J. Dyck,et al.  Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. , 2006, American journal of physiology. Heart and circulatory physiology.

[108]  C. Denny,et al.  Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans , 2006, Lipids in Health and Disease.

[109]  Ajay M Shah,et al.  Oxidative stress and redox signalling in cardiac hypertrophy and heart failure , 2006, Heart.

[110]  D. Vertommen,et al.  Insulin Antagonizes Ischemia-induced Thr172 Phosphorylation of AMP-activated Protein Kinase α-Subunits in Heart via Hierarchical Phosphorylation of Ser485/491* , 2006, Journal of Biological Chemistry.

[111]  J. Dhahbi,et al.  Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[112]  M. Szklo,et al.  Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2006, Diabetes care.

[113]  S. Kovacs,et al.  Long-term caloric restriction ameliorates the decline in diastolic function in humans. , 2006, Journal of the American College of Cardiology.

[114]  J. Lekakis,et al.  Polyphenols compounds from red grapes acutely improve endothelial function in patients with coronary heart disease , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[115]  X. Jia,et al.  Effects of trans‐resveratrol on hypertension‐induced cardiac hypertrophy using the partially nephrectomized rat model , 2005, Clinical and experimental pharmacology & physiology.

[116]  J. Corton,et al.  Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[117]  N. Maulik,et al.  Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. , 2005, Journal of molecular and cellular cardiology.

[118]  R. Ghidoni,et al.  Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. , 2005, The Journal of nutritional biochemistry.

[119]  R. Bolli,et al.  Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts. , 2005, Journal of molecular and cellular cardiology.

[120]  Marc A Pfeffer,et al.  Heart failure , 2005, The Lancet.

[121]  N. Renna,et al.  Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. , 2005, American journal of hypertension.

[122]  G. Cartee,et al.  Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. , 2005, Diabetes.

[123]  R. Marchelli,et al.  Bioavailability of trans-resveratrol from red wine in humans. , 2005, Molecular nutrition & food research.

[124]  Brian C. Smith,et al.  Mechanism of Human SIRT1 Activation by Resveratrol* , 2005, Journal of Biological Chemistry.

[125]  C. Leeuwenburgh,et al.  Age‐associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[126]  C. Auger,et al.  Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. , 2005, Journal of agricultural and food chemistry.

[127]  R. Weindruch,et al.  Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. , 2004, American journal of physiology. Endocrinology and metabolism.

[128]  J. Molkentin,et al.  Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. , 2004, Biochemical and biophysical research communications.

[129]  Li He,et al.  Mechanisms of cardiovascular protection by resveratrol. , 2004, Journal of medicinal food.

[130]  G. Biolo,et al.  Lack of direct effect of moderate hyperleptinemia to improve endothelial function in lean rat aorta: role of calorie restriction. , 2004, Atherosclerosis.

[131]  Anita Y. M. Chan,et al.  Activation of AMP-activated Protein Kinase Inhibits Protein Synthesis Associated with Hypertrophy in the Cardiac Myocyte* , 2004, Journal of Biological Chemistry.

[132]  Myriam Gorospe,et al.  Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.

[133]  Gary Williamson,et al.  Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. , 2004, Mutation research.

[134]  A. Shah,et al.  Role of oxidative stress in cardiac remodelling after myocardial infarction. , 2004, Heart, lung & circulation.

[135]  S. Klein,et al.  Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[136]  E. Bleecker,et al.  Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. , 2004, The American journal of clinical nutrition.

[137]  Hsin-Yi Huang,et al.  Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats , 2004, Clinical Cancer Research.

[138]  L. Hung,et al.  Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. , 2004, Free radical biology & medicine.

[139]  I. Gabriely,et al.  Caloric restriction, body fat and ageing in experimental models , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[140]  P. Shah,et al.  Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD , 2003, Thorax.

[141]  I. Shiojima,et al.  Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.

[142]  R. Hannan,et al.  Cardiac hypertrophy: A matter of translation , 2003, Clinical and experimental pharmacology & physiology.

[143]  N. Hollenberg.  Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. , 2003, Current hypertension reports.

[144]  L. Barenghi,et al.  Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. , 2003, European journal of pharmacology.

[145]  Joseph M. Wu,et al.  Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. , 2003, International journal of molecular medicine.

[146]  D. Ingram,et al.  Calorie restriction in rhesus monkeys , 2003, Experimental Gerontology.

[147]  Richard Weindruch,et al.  Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[148]  A. Vollmar,et al.  Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. , 2002, Molecular pharmacology.

[149]  A. Shah,et al.  Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure , 2002, Hypertension.

[150]  U. Förstermann,et al.  Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase , 2002, Circulation.

[151]  M. Portero-Otín,et al.  Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls , 2002, Mechanisms of Ageing and Development.

[152]  B. Wachowicz,et al.  Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. , 2002, Thrombosis research.

[153]  T. Broderick,et al.  Caloric restriction restores the cardioprotective effect of preconditioning in the rat heart , 2002, Mechanisms of Ageing and Development.

[154]  N. Maulik,et al.  Pharmacological preconditioning with resveratrol: role of nitric oxide. , 2002, American journal of physiology. Heart and circulatory physiology.

[155]  E. Ravussin,et al.  Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus , 2002, Annals of the New York Academy of Sciences.

[156]  C. Napoli,et al.  Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats. , 2002, American journal of physiology. Heart and circulatory physiology.

[157]  Hong Yang,et al.  Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice , 2002, Mechanisms of Ageing and Development.

[158]  T. Belke,et al.  Effects of chronic caloric restriction on mitochondrial respiration in the ischemic reperfused rat heart , 2002, Molecular and Cellular Biochemistry.

[159]  Y. Ouchi,et al.  Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. , 2001, The American journal of cardiology.

[160]  G. Barja,et al.  Caloric restriction decreases mitochondrial free radical generation at complex I and lowers oxidative damage to mitochondrial DNA in the rat heart , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[161]  G. Freeman,et al.  Calorie restriction attenuates inflammatory responses to myocardial ischemia-reperfusion injury. , 2001, American journal of physiology. Heart and circulatory physiology.

[162]  K. Jeng,et al.  Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation , 2001, Journal of Neuroimmunology.

[163]  K. Chayama,et al.  A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. , 2000, American journal of hypertension.

[164]  M. V. van Zwieten,et al.  The Relative Protective Effects of Moderate Dietary Restriction versus Dietary Modification on Spontaneous Cardiomyopathy in Male Sprague-Dawley Rats , 2000, Toxicologic pathology.

[165]  D. Ingram,et al.  Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[166]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[167]  AkiraTakeshita,et al.  Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium , 1999 .

[168]  D. Das,et al.  The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. , 1999, Free radical biology & medicine.

[169]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[170]  S. Delpal,et al.  Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. , 1999, Life sciences.

[171]  W. J. Wang,et al.  Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[172]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[173]  G. Taffet,et al.  The age-associated alterations in late diastolic function in mice are improved by caloric restriction. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[174]  J. VanNess,et al.  Antihypertensive effects of food‐intake restriction in aortic coarctation hypertension , 1997, Journal of hypertension.

[175]  L. Frémont,et al.  Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. , 1997, Biochemical pharmacology.

[176]  J. VanNess,et al.  Food restriction reduces sympathetic support of blood pressure in spontaneously hypertensive rats. , 1997, The Journal of nutrition.

[177]  D. Paulson.  The diabetic heart is more sensitive to ischemic injury. , 1997, Cardiovascular research.

[178]  R. S. Sohal,et al.  Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse , 1994, Mechanisms of Ageing and Development.

[179]  A. Waterhouse,et al.  Inhibition of human LDL oxidation by resveratrol , 1993, The Lancet.

[180]  T. Ozawa,et al.  Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. , 1992, Biochemical and biophysical research communications.

[181]  L. Landsberg,et al.  Caloric restriction lowers blood pressure in the spontaneously hypertensive rat. , 1978, Metabolism: clinical and experimental.

[182]  B. Stockman,et al.  1 SRT 1720 , SRT 2183 , SRT 1460 , AND RESVERATROL ARE NOT DIRECT ACTIVATORS OF SIRT 1 , 2010 .

[183]  G. Poli,et al.  Alternate-day fasting protects the rat heart against age-induced inflammation and fibrosis by inhibiting oxidative damage and NF-kB activation. , 2010, Free radical biology & medicine.

[184]  K. Pearson,et al.  Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging : role of circulating factors and SIRT 1 , 2009 .

[185]  H. Corke,et al.  Comparative analysis of bioactivities of four Polygonum species. , 2008, Planta Medica.

[186]  R. Ritchie,et al.  The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. , 2007, Antioxidants & redox signaling.

[187]  N. Maulik,et al.  Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1 , 2006, Cell Biochemistry and Biophysics.

[188]  Zhirong Wang,et al.  Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. , 2002, International journal of molecular medicine.

[189]  Y. Yamori,et al.  Protective Effect Of Resveratrol On Oxidative Damage In Male And Female Stroke‐Prone Spontaneously Hypertensive Rats , 2001, Clinical and experimental pharmacology & physiology.

[190]  C. Padovani,et al.  Myocardial function during chronic food restriction in isolated hypertrophied cardiac muscle. , 2000, The American journal of the medical sciences.

[191]  E. Masoro.  Caloric restriction. , 1998, Aging.

[192]  S. Swoap,et al.  Interaction of hypertension and caloric restriction on cardiac mass and isomyosin expression , 1995 .